Apyx Medical Corp Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Apyx Medical Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Apyx Medical Corp Debt-to-equity for the quarter ending September 30, 2024 was 278 %, a 364% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 278 +218 +364% Sep 30, 2024
Q2 2024 188 +140 +291% Jun 30, 2024
Q1 2024 132 +94.1 +250% Mar 31, 2024
Q4 2023 93.8 +63.2 +207% Dec 31, 2023
Q3 2023 60 +31.6 +111% Sep 30, 2023
Q2 2023 48.2 +21.5 +80.5% Jun 30, 2023
Q1 2023 37.7 +13.1 +53.3% Mar 31, 2023
Q4 2022 30.6 +8.09 +36% Dec 31, 2022
Q3 2022 28.4 +8.74 +44.5% Sep 30, 2022
Q2 2022 26.7 +8.67 +48.2% Jun 30, 2022
Q1 2022 24.6 +7.63 +45% Mar 31, 2022
Q4 2021 22.5 +5.88 +35.4% Dec 31, 2021
Q3 2021 19.6 +2.3 +13.3% Sep 30, 2021
Q2 2021 18 +1.75 +10.8% Jun 30, 2021
Q1 2021 17 +2.31 +15.8% Mar 31, 2021
Q4 2020 16.6 +3.37 +25.5% Dec 31, 2020
Q3 2020 17.3 +6.2 +55.7% Sep 30, 2020
Q2 2020 16.3 +1.95 +13.6% Jun 30, 2020
Q1 2020 14.7 -2.85 -16.3% Mar 31, 2020
Q4 2019 13.2 -8.99 -40.5% Dec 31, 2019
Q3 2019 11.1 -20.5 -64.8% Sep 30, 2019
Q2 2019 14.3 -25.5 -64% Jun 30, 2019
Q1 2019 17.5 -21.3 -54.9% Mar 31, 2019
Q4 2018 22.2 -15 -40.3% Dec 31, 2018
Q3 2018 31.6 -3.87 -10.9% Sep 30, 2018
Q2 2018 39.8 +3.23 +8.83% Jun 30, 2018
Q1 2018 38.8 +2.09 +5.69% Mar 31, 2018
Q4 2017 37.2 -0.46 -1.22% Dec 31, 2017
Q3 2017 35.5 -2.39 -6.31% Sep 30, 2017
Q2 2017 36.6 +0.35 +0.97% Jun 30, 2017
Q1 2017 36.7 +2.59 +7.59% Mar 31, 2017
Q4 2016 37.7 +4.79 +14.6% Dec 31, 2016
Q3 2016 37.9 -19.6 -34% Sep 30, 2016
Q2 2016 36.2 -59.6 -62.2% Jun 30, 2016
Q1 2016 34.1 -123 -78.3% Mar 31, 2016
Q4 2015 32.9 -266 -89% Dec 31, 2015
Q3 2015 57.5 -106 -64.9% Sep 30, 2015
Q2 2015 95.8 -1.99 -2.04% Jun 30, 2015
Q1 2015 157 +94.1 +149% Mar 31, 2015
Q4 2014 299 +264 +749% Dec 31, 2014
Q3 2014 164 +137 +521% Sep 30, 2014
Q2 2014 97.8 +72.6 +289% Jun 30, 2014
Q1 2014 63 +38.9 +161% Mar 31, 2014
Q4 2013 35.3 +11 +45.2% Dec 31, 2013
Q3 2013 26.3 +0.9 +3.54% Sep 30, 2013
Q2 2013 25.1 -0.71 -2.75% Jun 30, 2013
Q1 2013 24.1 -2.35 -8.89% Mar 31, 2013
Q4 2012 24.3 Dec 31, 2012
Q3 2012 25.4 Sep 30, 2012
Q2 2012 25.8 Jun 30, 2012
Q1 2012 26.4 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.